Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (21 quarters reported)
$160M in Q3 2020 → $29.4M now. Hover for any quarter.
As reported for the quarter ended September 30, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Kyverna Therapeutics Inc | 92.4% | Unchanged | 4,523,924 | $27.1M |
| Allogene Therapeutics Inc | 7.6% | Unchanged | 1,798,163 | $2.23M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2025 · filed November 03, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed July 10, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Kronos Bio, Inc. | Exited | −2,765,314 | −$2.28M | — |
quarter ended March 31, 2025 · filed April 03, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Centessa Pharmaceuticals PLC | Exited | −3,931,818 | −$65.9M | — |
| TT Tectonic Therapeutics, Inc. | Exited | −1,028,674 | −$47.5M | — |
| Dyne Therapeutics, Inc. | Exited | −407,499 | −$9.6M | — |
quarter ended December 31, 2024 · filed January 21, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed October 08, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| TT Tectonic Therapeutics, Inc. | New | +1,028,674 | +$31.2M | 22.5% |
quarter ended June 30, 2024 · filed July 10, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed April 12, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | New | +4,523,924 | +$112M | 62.4% |
| Dyne Therapeutics, Inc. | Trimmed | −1,667,288 | −$47.3M | 6.4% |
| Lianbio | Exited | −2,282,084 | −$10.2M | — |
| Kinnate Biopharma, Inc. | Exited | −2,207,772 | −$5.23M | — |
| IO Ikena Oncology, Inc. | Exited | −225,192 | −$444K | — |
quarter ended December 31, 2023 · filed January 05, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | Exited | −1,469,665 | −$2.51M | — |
| Dyne Therapeutics, Inc. | Trimmed | −145,247 | −$1.93M | 32.9% |
Loading...
